Men to Appear in Court After Suspected Cannabis Seizure
Cannabis criminalization impact continues to affect patient access and clinical relationships. Recent enforcement actions in Bournemouth led to court appearances after suspected cannabis seizures. This highlights the ongoing legal-medical disconnect…
PlantaRx CBD Gummies Reviewed: Don’t Buy Before Reading This
Product review articles for CBD gummies highlight the ongoing challenge clinicians face when patients seek guidance on unregulated consumer products. Without standardized dosing, third-party testing, or FDA oversight, these products present significant…
Wake and bake? Ontario may soon let weed stores open at 7 a.m. – Elliot Lake News
Ontario cannabis retail hours are under consideration to shift earlier to 7 a.m. This change may affect consumption timing and daily functioning for users. Clinicians should monitor how these new retail hours impact patient safety and treatment.
GLP-1 Receptor Agonist Risks: Long-Term Clinical Evidence
GLP-1 receptor agonist safety risks are critical for clinicians managing metabolic disease. Long-term clinical evidence supports FDA-approved therapies but warns of dangers from unregulated injections. Patient safety depends on verifying medication…
Exploring Cannabis Use in Cancer Treatment: Patient Safety & Communication
Cannabis use in cancer treatment raises important patient safety concerns and clinical communication needs. Self-medication with cannabis for cancer requires careful oversight to avoid delays in proven therapies. Oncology teams should address cannabis…
New medical cannabis clinic opens in the Highlands – WAVE 3
A new medical cannabis clinic opens in the Highlands, expanding access to regulated cannabis programs. This clinic emphasizes patient safety through evidence-based medicine. Such openings mark progress in standardized dosing and clinical oversight.
Alabama’s First Medical Cannabis Dispensary Launching in May 2024
The Alabama medical cannabis dispensary launch in May 2024 represents a historic step in expanding legal patient access. This launch introduces regulated cannabis access for qualifying patients under state oversight. Physicians and patients alike will…
Breakthroughs in THC Detection for Clinical Assessment and Safety
THC detection clinical assessment is critical for reliable cannabis impairment testing. New breathalyzer technology aims to detect recent cannabis use and functional impairment. This breakthrough supports patient safety and informed clinical decisions.
Appeal Dismissed in THC Impaired Driving Case Involving Child’s Death
The THC impaired driving legal case appeal was dismissed, reinforcing the complexities of cannabis impairment detection. THC blood levels do not reliably indicate impairment like alcohol. This case underscores the need for clear clinical guidance on…
Saskatchewan Court Upholds Stay in Fatal THC Driving Case
Legal precedents cannabis impairment cases shape how clinicians advise patients on driving safety. THC detection challenges complicate establishing impairment. This case highlights the need for clear clinical guidance.